We propose to identify the intracellular pathogenesis of Myelin Protein Zero (MPZ)-related neuropathies. We have created a unique set of transgenic mice expressing various human mutations of Mpz that provide proof of principle that gain of abnormal function, deriving from diverse intracellular locations, can cause variable myelinopathy phenotypes. In one model, POS63del, we have identified the unfolded protein response (UPR). Our hypothesis is that mutant proteins that elicit myelinopathies from intracellular locations away from myelin, produce more severe neuropathy because they more generally perturb Schwann cells (kill them by apoptosis) or the program of myelin protein and lipid synthesis. Here we will exploit our models, and in particular POS63del mice, to understand how intracellular retention of mutant proteins produces demyelination. We will fully evaluate the UPR downstream mediators in POS63del nerves, and explore how the S63 alteration produces an unfolded protein. We will genetically eliminate the unfolded protein response mediator, CHOP, and characterize the effect on neuropathy to show that the UPR causes demyelinating neuropathy. We will systematically identify target genes of the CHOP transcription factor in diseased nerve, in order to test our hypothesis that the 'toxic'effect is on pivotal regulators, or multiple members of the program of myelin protein and lipid synthesis. Finally, we will explore in a novel proteasome indicator mouse whether the UPR induces inefficient proteasome function and thereby alters the physiological degradation of proteins such as PMP22, thereby inducing a PMP22 overexpression neuropathy. Charcot Marie Tooth hereditary neuropathies affect 150,000 people in the US and 3,000,000 people worldwide and account for significant lifelong disability and important economic loss. About one quarter of these neuropathies result from mutations that permit the expression of 'toxic1 proteins that interfere with the capacity of Schwann cells to form and maintain myelin in nerves. Little is known about the mechanisms of toxicity. This study will identify some of these mechanisms, and inform potential therapeutic strategies for hereditary neuropathies. The same mechanisms and strategies may also be relevant to the broad category of diseases associated with misfolded proteins including Alzheimer disease and Diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS055256-05
Application #
7754652
Study Section
Neurodegeneration and Biology of Glia Study Section (NDBG)
Program Officer
Gwinn, Katrina
Project Start
2006-04-01
Project End
2012-01-31
Budget Start
2010-02-01
Budget End
2012-01-31
Support Year
5
Fiscal Year
2010
Total Cost
$233,593
Indirect Cost
Name
Fondazone Cent/San Raffaele/Del Monte
Department
Type
DUNS #
440850089
City
Milan
State
Country
Italy
Zip Code
20132
Poitelon, Yannick; Lopez-Anido, Camila; Catignas, Kathleen et al. (2016) YAP and TAZ control peripheral myelination and the expression of laminin receptors in Schwann cells. Nat Neurosci 19:879-87
Beirowski, Bogdan; Babetto, Elisabetta; Wrabetz, Lawrence (2016) Axon degeneration: Linking axonal bioenergetics to myelin. J Cell Biol 215:437-440
Musner, Nicolò; Sidoli, Mariapaola; Zambroni, Desireè et al. (2016) Perk Ablation Ameliorates Myelination in S63del-Charcot-Marie-Tooth 1B Neuropathy. ASN Neuro 8:
Poitelon, Y; Bogni, S; Matafora, V et al. (2015) Spatial mapping of juxtacrine axo-glial interactions identifies novel molecules in peripheral myelination. Nat Commun 6:8303
Das, Indrajit; Krzyzosiak, Agnieszka; Schneider, Kim et al. (2015) Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit. Science 348:239-42
Colombelli, Cristina; Palmisano, Marilena; Eshed-Eisenbach, Yael et al. (2015) Perlecan is recruited by dystroglycan to nodes of Ranvier and binds the clustering molecule gliomedin. J Cell Biol 208:313-29
Pellegatta, Marta; De Arcangelis, Adèle; D'Urso, Alessandra et al. (2013) ?6?1 and ?7?1 integrins are required in Schwann cells to sort axons. J Neurosci 33:17995-8007
D'Antonio, Maurizio; Musner, Nicolò; Scapin, Cristina et al. (2013) Resetting translational homeostasis restores myelination in Charcot-Marie-Tooth disease type 1B mice. J Exp Med 210:821-38
Patzkó, Agnes; Bai, Yunhong; Saporta, Mario A et al. (2012) Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice. Brain 135:3551-66
Wang, Lijun; Pytel, Peter; Feltri, M Laura et al. (2012) Selective knockdown of mutant SOD1 in Schwann cells ameliorates disease in G85R mutant SOD1 transgenic mice. Neurobiol Dis 48:52-7

Showing the most recent 10 out of 31 publications